Non-ownership Filings
| Preliminary Results for Year Ended 30 June 2025 | Oct. 23, 2025 |
| Update on toxicology study for SDC-1801 | Oct. 10, 2025 |
| Notice of Results and Investor Presentation | Oct. 07, 2025 |
| Exercise of Warrants | Sep. 26, 2025 |
| Exercise of Warrants | Sep. 18, 2025 |
| Exercise of Warrants | Aug. 26, 2025 |
| Exercise of Warrants | Aug. 20, 2025 |
Ownership Update Filings
| Director’s Dealing | Mar. 27, 2025 |
| Completion of Equity Fundraise | Apr. 04, 2024 |
| Director Dealings | Nov. 08, 2023 |
| Exercise of Share Options and Director Dealings | Nov. 02, 2023 |
| Director's Dealing | Sep. 06, 2023 |
| Director Dealing | Sep. 05, 2023 |
| Director/PDMR Shareholding | Nov. 23, 2021 |